Cowen Maintains Buy on PRCT PROCEPT BioRobotics Corporation Feb 2026
On Feb 26, 2026, Cowen & Co. maintained its Buy on PROCEPT BioRobotics Corporation (PRCT), the headline in this PRCT analyst rating update. Cowen described itself as “constructive after the big stock decline,” keeping the buy stance despite a recent earnings shortfall and pressure on the shares.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
